IBDEI0J4 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19268,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,19269,0)
 ;;=L40.1^^86^983^256
 ;;^UTILITY(U,$J,358.3,19269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19269,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,19269,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,19269,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,19270,0)
 ;;=L40.2^^86^983^11
 ;;^UTILITY(U,$J,358.3,19270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19270,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,19270,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,19270,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,19271,0)
 ;;=L40.3^^86^983^255
 ;;^UTILITY(U,$J,358.3,19271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19271,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,19271,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,19271,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,19272,0)
 ;;=L40.4^^86^983^157
 ;;^UTILITY(U,$J,358.3,19272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19272,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,19272,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,19272,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,19273,0)
 ;;=L40.8^^86^983^252
 ;;^UTILITY(U,$J,358.3,19273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19273,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,19273,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,19273,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,19274,0)
 ;;=L40.9^^86^983^254
 ;;^UTILITY(U,$J,358.3,19274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19274,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,19274,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,19274,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,19275,0)
 ;;=L50.9^^86^983^286
 ;;^UTILITY(U,$J,358.3,19275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19275,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,19275,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,19275,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,19276,0)
 ;;=L53.8^^86^983^147
 ;;^UTILITY(U,$J,358.3,19276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19276,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,19276,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,19276,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,19277,0)
 ;;=L53.9^^86^983^146
 ;;^UTILITY(U,$J,358.3,19277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19277,1,3,0)
 ;;=3^Erythematous Condition,Unspec
 ;;^UTILITY(U,$J,358.3,19277,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,19277,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,19278,0)
 ;;=L54.^^86^983^145
 ;;^UTILITY(U,$J,358.3,19278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19278,1,3,0)
 ;;=3^Erythema in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,19278,1,4,0)
 ;;=4^L54.
 ;;^UTILITY(U,$J,358.3,19278,2)
 ;;=^5009211
 ;;^UTILITY(U,$J,358.3,19279,0)
 ;;=L56.0^^86^983^139
 ;;^UTILITY(U,$J,358.3,19279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19279,1,3,0)
 ;;=3^Drug Phototoxic Response
 ;;^UTILITY(U,$J,358.3,19279,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,19279,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,19280,0)
 ;;=L56.1^^86^983^138
 ;;^UTILITY(U,$J,358.3,19280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19280,1,3,0)
 ;;=3^Drug Photoallergic Response
 ;;^UTILITY(U,$J,358.3,19280,1,4,0)
 ;;=4^L56.1
 ;;^UTILITY(U,$J,358.3,19280,2)
 ;;=^5009215
 ;;^UTILITY(U,$J,358.3,19281,0)
 ;;=L56.2^^86^983^236
 ;;^UTILITY(U,$J,358.3,19281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19281,1,3,0)
 ;;=3^Photocontact Dermatitis
 ;;^UTILITY(U,$J,358.3,19281,1,4,0)
 ;;=4^L56.2
 ;;^UTILITY(U,$J,358.3,19281,2)
 ;;=^5009216
 ;;^UTILITY(U,$J,358.3,19282,0)
 ;;=L56.3^^86^983^268
 ;;^UTILITY(U,$J,358.3,19282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19282,1,3,0)
 ;;=3^Solar Urticaria
 ;;^UTILITY(U,$J,358.3,19282,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,19282,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,19283,0)
 ;;=L57.0^^86^983^12
 ;;^UTILITY(U,$J,358.3,19283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19283,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,19283,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,19283,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,19284,0)
 ;;=L60.0^^86^983^161
 ;;^UTILITY(U,$J,358.3,19284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19284,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,19284,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,19284,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,19285,0)
 ;;=L60.1^^86^983^234
 ;;^UTILITY(U,$J,358.3,19285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19285,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,19285,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,19285,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,19286,0)
 ;;=L60.2^^86^983^233
 ;;^UTILITY(U,$J,358.3,19286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19286,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,19286,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,19286,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,19287,0)
 ;;=L60.3^^86^983^170
 ;;^UTILITY(U,$J,358.3,19287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19287,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,19287,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,19287,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,19288,0)
 ;;=L60.4^^86^983^88
 ;;^UTILITY(U,$J,358.3,19288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19288,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,19288,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,19288,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,19289,0)
 ;;=L60.5^^86^983^290
 ;;^UTILITY(U,$J,358.3,19289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19289,1,3,0)
 ;;=3^Yellow Nail Syndrome
 ;;^UTILITY(U,$J,358.3,19289,1,4,0)
 ;;=4^L60.5
 ;;^UTILITY(U,$J,358.3,19289,2)
 ;;=^5009238
 ;;^UTILITY(U,$J,358.3,19290,0)
 ;;=L60.8^^86^983^168
 ;;^UTILITY(U,$J,358.3,19290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19290,1,3,0)
 ;;=3^Nail Disorders NEC
 ;;^UTILITY(U,$J,358.3,19290,1,4,0)
 ;;=4^L60.8
 ;;^UTILITY(U,$J,358.3,19290,2)
 ;;=^5009239
 ;;^UTILITY(U,$J,358.3,19291,0)
 ;;=L62.^^86^983^169
 ;;^UTILITY(U,$J,358.3,19291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19291,1,3,0)
 ;;=3^Nail Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,19291,1,4,0)
 ;;=4^L62.
 ;;^UTILITY(U,$J,358.3,19291,2)
 ;;=^5009241
 ;;^UTILITY(U,$J,358.3,19292,0)
 ;;=L64.9^^86^983^33
 ;;^UTILITY(U,$J,358.3,19292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19292,1,3,0)
 ;;=3^Androgenic Alopecia,Unspec
 ;;^UTILITY(U,$J,358.3,19292,1,4,0)
 ;;=4^L64.9
 ;;^UTILITY(U,$J,358.3,19292,2)
 ;;=^5009249
 ;;^UTILITY(U,$J,358.3,19293,0)
 ;;=L65.9^^86^983^231
 ;;^UTILITY(U,$J,358.3,19293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19293,1,3,0)
 ;;=3^Nonscarring Hair Loss,Unspec
 ;;^UTILITY(U,$J,358.3,19293,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,19293,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,19294,0)
 ;;=L70.0^^86^983^6
 ;;^UTILITY(U,$J,358.3,19294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19294,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,19294,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,19294,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,19295,0)
 ;;=L70.1^^86^983^1
 ;;^UTILITY(U,$J,358.3,19295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19295,1,3,0)
 ;;=3^Acne Conglobata
 ;;^UTILITY(U,$J,358.3,19295,1,4,0)
 ;;=4^L70.1
 ;;^UTILITY(U,$J,358.3,19295,2)
 ;;=^5009269
 ;;^UTILITY(U,$J,358.3,19296,0)
 ;;=L70.3^^86^983^5
 ;;^UTILITY(U,$J,358.3,19296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19296,1,3,0)
 ;;=3^Acne Tropica
 ;;^UTILITY(U,$J,358.3,19296,1,4,0)
 ;;=4^L70.3
 ;;^UTILITY(U,$J,358.3,19296,2)
 ;;=^5009270
 ;;^UTILITY(U,$J,358.3,19297,0)
 ;;=L70.5^^86^983^2
 ;;^UTILITY(U,$J,358.3,19297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19297,1,3,0)
 ;;=3^Acne Excoriee des Jeunes Filles
 ;;^UTILITY(U,$J,358.3,19297,1,4,0)
 ;;=4^L70.5
 ;;^UTILITY(U,$J,358.3,19297,2)
 ;;=^5009272
 ;;^UTILITY(U,$J,358.3,19298,0)
 ;;=L70.8^^86^983^4
 ;;^UTILITY(U,$J,358.3,19298,1,0)
 ;;=^358.31IA^4^2
